Ethics and public serviceUHR, J.Australian Journal of Public Administration. 1988, Vol 67, Num 2, pp 109-118Article

THE ACTIVATION OF MURINE B CELLS: THE ROLE OF SURFACE IMMUNOGLOBULINSVITETTA E; PURE E; ISAKSON P et al.1980; IMMUNOL. REV.; DNK; DA. 1980; VOL. 52; PP. 211-231; BIBL. 3 P.Article

CON-A-ACTIVATED T CELLS SECRETE FACTORS WITH POLYCLONAL B-CELL-ACTIVATING PROPERTIESPRIMI D; HAMMARSTROM L; MOLLER G et al.1979; SCAND. J. IMMUNOL.; NOR; DA. 1979; VOL. 9; NO 5; PP. 467-475; BIBL. 15 REF.Article

Flowcytometry- principles and feasibility in transfusion medicine. Enumeration of epithelial derived tumor cells in peripheral bloodTERSTAPPEN, L. W. M. M; RAO, C; GROSS, S et al.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 269-274, issn 0042-9007, SUP2Conference Paper

Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma : a phase I studySAUSVILLE, E. A; HEADLEE, D; GHETIE, V et al.Blood. 1995, Vol 85, Num 12, pp 3457-3465, issn 0006-4971Article

Cancer dormancy : Role of cyclin-dependent kinase inhibitors in induction of cell cycle arrest mediated via membrane IgMMARCHES, R; SCHEUERMANN, R. H; UHR, J. W et al.Cancer research (Baltimore). 1998, Vol 58, Num 4, pp 691-697, issn 0008-5472Article

Determination of metals in aqueous solution by direct nebulization into an air microwave induced plasmaUHR, J. J; CARNAHAN, J. W.Analytical chemistry (Washington, DC). 1985, Vol 57, Num 7, pp 1253-1255, issn 0003-2700Article

The potential use of immunotoxins in transplantation, cancer therapy, and immunoregulationVITETTA, E. S; UHR, J. W.Transplantation. 1984, Vol 37, Num 6, pp 535-538, issn 0041-1337Article

ImmunotoxinsVITETTA, E. S; UHR, J. W.Annual review of immunology. 1985, Vol 3, pp 197-212, issn 0732-0582Article

Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cellsVITETTA, E. S; CUSHLEY, W; UHR, J. W et al.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1983, Vol 80, Num 20, pp 6332-6335, issn 0273-1134Article

Monoclonal antibodies as agonists : an expanded role for their use in cancer therapyVITETTA, E. S; UHR, J. W.Cancer research (Baltimore). 1994, Vol 54, Num 20, pp 5301-5309, issn 0008-5472Article

Cross-linking of interleukin 4 to surface molecules on murine T and B lymphocytesFERNANDEZ-BOTRAN, R; UHR, J. W; VITETTA, E. S et al.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 11, pp 4235-4239, issn 0027-8424Article

The effect of antibody valency and lysosomotropic amines on the synergy between ricin a chain- and ricin B chain-containing immunotoxinsFULTON, R. J; UHR, J. W; VITETTA, E. S et al.The Journal of immunology (1950). 1986, Vol 136, Num 8, pp 3103-3109, issn 0022-1767Article

Cell cycle-related expression of the receptor for A B cell differentiation factorBROOKS, K. H; UHR, J. W; VITETTA, E. S et al.The Journal of immunology (1950). 1985, Vol 134, Num 2, pp 742-747, issn 0022-1767Article

Immunotoxins : magic bullets or misguided missiles ?VITELLA, E. S; THORPE, P. E; UHR, J. W et al.Immunology today (Amsterdam. Regular ed.). 1993, Vol 14, Num 6, pp 252-259, issn 0167-5699Article

In vivo therapy of the BCL₁ tumor: effect of immunotoxin valency and deglycosylation of the ricin A chainFULTON, R. J; UHR, J. W; VITETTA, E. S et al.Cancer research (Baltimore). 1988, Vol 48, Num 9, pp 2626-2631, issn 0008-5472Article

Antigen-specific memory and virgin B cells differ in their requirements for conjugation to T cellsSANDERS, V. M; UHR, J. W; VITETTA, E. S et al.Cellular immunology (Print). 1987, Vol 104, Num 2, pp 419-425, issn 0008-8749Article

Synthesis of germ-line γ1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon γBERTON, M. T; UHR, J. W; VITETTA, E. S et al.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 8, pp 2829-2833, issn 0027-8424, 5 p.Article

A B cell growth factor-like activity is secreted by cloned, neoplastic B cellsBROOKS, K. H; UHR, J. W; VITETTA, E. S et al.The Journal of immunology (1950). 1984, Vol 133, Num 6, pp 3133-3137, issn 0022-1767Article

The autitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either and anti-CD19 antibody or an anti-CD19 immunotoxinGHETIE, M.-A; TUCKER, K; RICHARDSON, T et al.Blood. 1992, Vol 80, Num 9, pp 2315-2320, issn 0006-4971Article

Pharmacokinetics of tumor-reactive immunotoxins in tumor-bearing mice: effect of antibody valency and deglycosylation of the ricin A chain on clearance and tumor localizationFULTON, R. J; TUCKER, T. F; VITETTA, E. S et al.Cancer research (Baltimore). 1988, Vol 48, Num 9, pp 2618-2625, issn 0008-5472Article

Interleukin 4 enhances the ability of antigen-specific B cells to form conjugates with T cellsSANDERS, V. M; FERNANDEZ-BOTRAN, R; UHR, J. W et al.The Journal of immunology (1950). 1987, Vol 139, Num 7, pp 2349-2354, issn 0022-1767Article

B cell―stimulatory factor 1 (BSF-1) promotes growth of helper T cell linesFERNANDEZ-BOTRAN, R; KRAMMER, P. H; DIAMANTSTEIN, T et al.The Journal of experimental medicine. 1986, Vol 164, Num 2, pp 580-593, issn 0022-1007Article

Tumor dormancy. I: Regression of BCL₁ tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complexSIU, H; VITETTA, E. S; MAY, R. D et al.The Journal of immunology (1950). 1986, Vol 137, Num 4, pp 1376-1382, issn 0022-1767Article

B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growthOLIVER, K; NOELLE, R. J; UHR, J. W et al.Proceedings of the National Academy of Sciences of the United States of America. 1985, Vol 82, Num 8, pp 2465-2467, issn 0027-8424Article